SCHEMBL15069783

SCHEMBL15069783

O=CCCc1ccc2[nH]ncc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.55
NOS1 P29475 4/20 0.46
ROCK2 O75116 3/20 0.46
ROCK1 Q13464 3/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
METAP2 P50579 1/20 0.46
CSNK2A1 P68400 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 1/20 0.46
HIF1A Q16665 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
POLB P06746 1/20 0.44
MAOB P27338 1/20 0.44
GRIN2B Q13224 2/20 0.43
CLK1 P49759 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8666610 0.84 NOS1 (0.57) MAPK1NOS1ROCK2ROCK1MAPT
SCHEMBL27623287 0.80 MAPK1 (0.48) MAPK1NOS1ROCK2ROCK1MAPT
SCHEMBL27885403 0.78 MAPK1 (0.51) MAPK1NOS1ROCK2ROCK1MAPT
SCHEMBL8220180 0.78 ROCK2 (0.54) MAPK1NOS1ROCK2ROCK1MAPT
SCHEMBL27998026 0.78 MAPK1 (0.56) MAPK1NOS1ROCK2ROCK1MAPT
SCHEMBL27995718 0.78 NOS1 (0.55) MAPK1NOS1ROCK2ROCK1MAPT
SCHEMBL6585051 0.77 ROCK2 (0.58) MAPK1NOS1ROCK2ROCK1MAPT
SCHEMBL25205712 0.76 MAPK1 (0.55) MAPK1ROCK2ROCK1MEN1KMT2A
SCHEMBL30564484 0.76 MAPK1 (0.55) MAPK1ROCK2ROCK1MEN1KMT2A
SCHEMBL9223010 0.75 ROCK2 (0.50) MAPK1NOS1ROCK2ROCK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797889-A1 NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS Centaurus Biopharma Co., Ltd. (CN) 2014-11-05 EP disclosed
WO-2013097773-A1 NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS CENTAURUS BIOPHARMA CO., LTD. (CN) 2013-07-04 WO disclosed